Explore
Validate
LearnAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-17837 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Phospho-PKC zeta/lambda (Thr410, Thr403) Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- It is not recommended to aliquot this antibody.
Submitted references Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion.
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS, Apostolatos CA, Breedy S, Dennison CL, Hill R, Acevedo-Duncan M
Cell adhesion & migration 2021 Dec;15(1):37-57
Cell adhesion & migration 2021 Dec;15(1):37-57
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Ratnayake WS, Apostolatos AH, Ostrov DA, Acevedo-Duncan M
International journal of oncology 2017 Nov;51(5):1370-1382
International journal of oncology 2017 Nov;51(5):1370-1382
No comments: Submit comment
No validations: Submit validation data